Targeted Strategies for Today's Evolving Markets

MissionIR Blog Inc. (CIIX) Capitalizing on Growing Demand for CBD-Infused Health and Wellness Product Lines

  • Inc.’s consumer product line has been rebranded under the new ‘opt’ brand
  • CEO Warren Wang sees potential to uplist to the NYSE or Nasdaq Small Cap Market as company reaches up to $10 million in annual volume
  • Subscription revenues for premier financial information website targeting Chinese-speaking investors increased by 40 percent year-over-year Inc. (OTCQB: CIIX), developer of a proprietary financial news media and content platform providing information to the global Chinese-speaking community, is following a promising game plan that includes consolidation of the its domestic consumer sites into a single channel to provide a one-stop shop for consumers weary of searching the world wide web. CIIX CEO Warren Wang said in a news release that a rebranding of its subsidiary, Inc., under the company’s new ‘opt’ brand will offer consumers in the United States a wide variety of premier CBD-infused product lines (

Consumers should visit to find the latest ‘opt’ brands, which currently include two lines: opt Hemp and opt2mist ( The opt Hemp line includes gummies, oils, soft gels and cosmetics. Additional hemp-derived CBD products are in development. The company’s opt2mist is a spray-vitamin line of products in development that will also offer full-spectrum, hemp-derived CBD-infused formulas.

“The unification of our domestic consumer products under the opt brand is a step in the right direction to building optimal brand recognition as we continue to roll out our new industrial, hemp-infused CBD products and other health and wellness products, such as the opt2mist sprays, throughout 2019 and beyond,” Wang said in the news release.

Through its primary website,, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational services in Chinese language character sets; consultative services to smaller private companies considering going public; and advertising and public relations support services.

Wang, who founded in 1999 and has been at the helm ever since, is enthusiastic about the company’s path forward. In an interview on MoneyTV with Donald Baillargeon, Wang shared that he intends for the company to uplist to the New York Stock Exchange or Nasdaq Small Cap Market as it reaches up to $10 million in annual volume (

“I’m pretty confident that we will see profitability and revenue growth in the next three to five years,” Wang said in the interview. “Our other goal is uplisting to the New York Stock Exchange (NYSE) or to Nasdaq because we are looking at an acquisition, and we are looking for revenue of $6 million to $10 million in the next three to five years. I think we will definitely qualify for NYSE or Nasdaq on the small cap side.”

The company recently announced its financial results for the second quarter of fiscal year 2019, pinpointing several important accomplishments. A revenue increase of more than 50 percent year-over-year is one of the key milestones presented in a January 22, 2019, news release ( One of the biggest drivers for the excellent financial performance was the increase in hemp and CBD sales revenue. Year-over-year, hemp and CBD sales revenues were up by eight percent, while subscription revenues for the premier financial information website targeting Chinese-speaking investors also increased by 40 percent year-over-year. is looking forward to an even stronger performance in the upcoming months, as noted by Wang. He added, “As we leverage the momentum already in place, we look forward to having an even stronger second half for FY 2019.”

For more information, visit the company’s website at

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit

MissionIR (MIR)
Atlanta, Georgia
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published:

This entry was posted in, Inc. CIIX. Bookmark the permalink.

Comments are closed.